Sealing The Deal: O'Melveny Nails Historic Buy For China's BGI

Law360, New York (April 30, 2013, 4:22 PM EDT) -- While most Americans were sitting down to a turkey dinner, a group of O'Melveny & Myers LLP attorneys spent their Thanksgiving holiday last November responding to a third-party offer that threatened to derail a historic acquisition by their client, Chinese genome sequencing company BGI-Shenzhen.

BGI had reached an agreement to acquire genome technology firm Complete Genomics Inc. for $117.6 million in September, the first-ever acquisition of a U.S. public company by a Chinese firm. But BGI's U.S. rival, Illumina Inc., made an unsolicited competing offer while...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.